Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization
- 1 April 2001
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 184 (5) , 1015-1020
- https://doi.org/10.1067/mob.2001.112970
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Red cell antibodies in pregnancy: there is no ‘critical titre’Transfusion Medicine, 1995
- Prediction of the Severity of Haemolytic Disease of the Newborn: Quantitative IgG Anti‐D Subclass Determinations Explain the Correlation with Functional Assay ResultsVox Sanguinis, 1995
- Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newbornActa Obstetricia et Gynecologica Scandinavica, 1994
- Complications of fetal blood samplingAmerican Journal of Obstetrics and Gynecology, 1993
- Management of fetal hemolytic disease by cordocentesisAmerican Journal of Obstetrics and Gynecology, 1991
- 6 ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodiesBailliere's Clinical Haematology, 1990
- Consequences of fetomaternal haemorrhage after intrauterine transfusion.BMJ, 1988
- Diagnostic fetal umbilical blood sampling in the management of isoimmunizationAmerican Journal of Obstetrics and Gynecology, 1988
- Prediction of the Outcome of Rhesus Haemolytic Disease of the Newborn: Additional Information Using an ADCC AssayVox Sanguinis, 1984
- The Rh problem in obstetrics and a new concept of its management using amniocentesis and spectrophotometric scanning of amniotic fluidAmerican Journal of Obstetrics and Gynecology, 1965